<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="antibiotics-10-00584-t004" orientation="portrait" position="float">
 <object-id pub-id-type="pii">antibiotics-10-00584-t004_Table 4</object-id>
 <label>Table 4</label>
 <caption>
  <p>Biological activities of ajowan and thyme chemotype thymol essential oils (AW-S1 to S8 and TT-S1 to S8), the chemical compounds and the mixtures (M1 to M11). The cytotoxic activity was assessed on the keratinocyte cell line (HaCaT) and direct activity and indirect (in association with the penicillin V (PEN V)) antibacterial activity were assessed against two Gram-positive bacteria, 
   <italic>Staphylococcus aureus</italic> LMG 21,674 (FUSR) and LMG 15,875 (MRSA).
  </p>
 </caption>
 <graphic xlink:href="antibiotics-10-00584-i001" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 <table-wrap-foot>
  <fn>
   <p>AB—antibiotic, AWT—mixture type ajowan (50% thymol, 25% 
    <italic>γ</italic>-terpinene, 20% 
    <italic>p</italic>-cymene, and 5% 
    <italic>β</italic>-pinene), TTT—mixture type thymol thyme (50% thymol, 20% 
    <italic>p</italic>-cymene, 10% 
    <italic>γ</italic>-terpinene, 5% 
    <italic>β</italic>-myrcene, 5% linalool, 5% 
    <italic>β</italic>-caryophyllene, and 5% carvacrol), TX—X percentage of thymol, 
    <italic>p</italic>X—X percentage of 
    <italic>p</italic>-cymene, 
    <italic>γ</italic>X—X percentage of 
    <italic>γ</italic>-terpinene, CX—X percentage of carvacrol, 
    <italic>β</italic>CX—X percentage of 
    <italic>β</italic>-caryophyllene.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
